Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
US6949345B1 · kind B1 · utility
3Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 17, 1998 |
| Grant date | Sep 27, 2005 |
| Priority date | — |
| Expiry date | Nov 17, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5695
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to peptide sequences enabling mycobacteria to adhere to host cells (e.g., epithelial cells). More particularly, the invention relates to a mycobacterial heparin-binding haemagglutinin type antigen from M. bovis ECG or M. tuberculosis. The invention also relates to a recombinant peptide sequence enabling mycobacteria to adhere to host cells. The polypeptides can be used to prepare vaccines against mycobacterial infections and for serological diagnosis of mycobacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.